CAH

In the past six months, Cardinal Health's stock has experienced various movements. The stock price increased by 26.09% over the last 12 months, but saw a year-to-date return of -6.91% and a decrease of 9.90% in the past month. The company announced its third-quarter fiscal year 2026 earnings, reporting $3.17 earnings per share, which beat analysts' consensus estimates, but revenue missed expectations. The company raised its full-year fiscal 2026 non-GAAP EPS and adjusted free cash flow guidance. The Board of Directors approved an increase to its quarterly dividend to $0.5158 per share. JPMorgan Chase & Co. lowered its price target on Cardinal Health from $243.00 to $215.00, maintaining a neutral rating.